65,228 international patients went to Korea for a health checkup in 2025, up from 55,762 the year before, a rise of 17.0%. That is the national figure, and it is not the one usually quoted. The number in wider circulation is 11,780 rising to 15,695, a rise of 33.2%, which is the United States column of the same table read as though it were the total.
Korea publishes unusually good data on this. Two agencies release it on a known schedule, the breakdowns go down to department and nationality, and it is free. The counting rules are also specific enough that quoting the figures without reading them is a reliable way to say something untrue, and the checkup numbers are a clean illustration.
What 실환자 means, and why it matters
Korea’s headline figure for 2025 is 2,011,822 international patients. That word “patients” is doing more work than it looks.
The count is of 실환자, unique patients per institution. If one person has a dermatology consultation at one clinic, a checkup at a second and a follow-up at a third, they appear three times in the national total. There is a separate visit-weighted series called 연환자 which is roughly 35% larger again, counting each episode of care.
Two exclusions matter as much as the inclusions. The statistics leave out foreign residents of Korea and anyone enrolled in Korean national health insurance. So this is not a count of non-Korean people receiving care in Korea. It is specifically a count of people who came from elsewhere as patients, which happens to be the population a medical-travel service cares about, but it is narrower than “foreigners treated in Korea” and wider than “individual medical tourists.”
Anyone writing “2.01 million patient visits” has used the wrong word twice over. They are not visits, and the underlying people number fewer than the count.
The checkup figures, correctly attributed
Here is the comparison that gets collapsed.
| Population | 2024 | 2025 | Change |
|---|---|---|---|
| All nationalities | 55,762 | 65,228 | +17.0% |
| United States only | 11,780 | 15,695 | +33.2% |
Both rows are real and both are interesting. The American row is growing about twice as fast as the whole, which is a genuine signal and the more relevant one if you are an American reader deciding whether this is a well-trodden path or an unusual one. But it is one column, and presenting +33.2% as the growth in Korea’s checkup market attributes American behaviour to everybody.
The related claim, that health checkups overtook plastic surgery, has the same shape. Among American patients in 2024, checkups at 11,780 did exceed plastic surgery at 11,250. It reversed the next year. As a statement about all international patients in Korea it was never true at all: cosmetic and dermatological care dominates the totals by a wide margin.
The American growth figure that is solid
One number in this area is both large and confirmed. US patient visits to Korea reached 173,363 in 2025, up 70.4% in a single year, the highest count since Korea began keeping these records in 2009. That comes from the Ministry of Health and Welfare’s own press release.
Two qualifications, neither of which undoes it. The word in the source is 실환자 again, so it carries the same per-institution counting as the headline. And 70.4% growth in one year invites a question the figure alone does not answer, which is how much of it is recovery from a suppressed base rather than new demand. This article does not have that answer and will not manufacture one.
Departmental shares have their own trap
You will see it written that 62.9% of Korea’s 2025 international patients went to dermatology and 11.2% to plastic surgery. Those percentages are correct, and their denominator is not the headline.
They are shares of 2,087,400 department-patient counts, not of the 2,011,822 patient headline. The department table sums higher than the patient total because one patient seen in two departments is counted in both. Divide the same department figures by the headline instead and you get slightly different percentages. It is a small distortion and it is the kind that compounds when someone builds an argument on it.
Where to look, and when
Korea releases this data in two stages, which is worth knowing because the two get conflated.
- 보건복지부, the Ministry of Health and Welfare, publishes the headline figures in a press release each April, covering the previous calendar year.
- KHIDI, the Korea Health Industry Development Institute, publishes the fuller 통계분석보고서 with country-level and institution-type breakdowns later in the year.
The commonly repeated claim that KHIDI’s report lands in October or November is out of date. Recent editions have arrived in June or July. As of this writing the 2025-data edition has not appeared, which means every deeper cut in circulation, including the tertiary-hospital and serious-illness breakdowns by country, is still running on 2024 data even where the surrounding article carries a 2025 headline.
Why a booking site is writing this
Because the numbers are the reason we can be checked. Korean law requires providers to publish their non-covered prices, Korea publishes its foreign-patient statistics in detail, and the cancer registry publishes stage-level survival. That combination is unusual and it is the substance behind most of the honest claims on this site.
It cuts both ways, though. Data that detailed is also easy to quote in a way that flatters whoever is quoting it, and the checkup figures above show three separate ways to do that by accident: read one country’s column as the total, attach the wrong denominator to a percentage, or use a word like “visits” for a count that is not visits. None of those requires bad faith. They only require not reading the notes on the table.
If you are comparing what different services tell you about Korea, the useful question is not whose number is bigger. It is whether the number comes with its counting basis attached.